-
Signature
-
/s/ Timothy Bixby, Attorney-in-Fact for Adina Eckstein
-
Issuer symbol
-
LMND
-
Transactions as of
-
05 Aug 2025
-
Transactions value $
-
-$247,925
-
Form type
-
4
-
Filing time
-
07 Aug 2025, 17:33:26 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Eckstein Adina |
Chief Operating Officer |
C/O LEMONADE, INC., 5 CROSBY STREET, 3RD FLOOR, NEW YORK |
/s/ Timothy Bixby, Attorney-in-Fact for Adina Eckstein |
07 Aug 2025 |
0001874702 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
LMND |
COMMON STOCK |
Options Exercise |
$29,612 |
+1,250 |
+0.66% |
$23.69 |
190,903 |
05 Aug 2025 |
Direct |
|
| transaction |
LMND |
COMMON STOCK |
Options Exercise |
$88,837 |
+3,750 |
+1.96% |
$23.69 |
194,653 |
05 Aug 2025 |
Direct |
|
| transaction |
LMND |
COMMON STOCK |
Sale |
-$245,000 |
-5,000 |
-2.57% |
$49 |
189,653 |
05 Aug 2025 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
LMND |
STOCK OPTION |
Options Exercise |
-$29,612 |
-1,250 |
-100% |
$23.69 |
0 |
05 Aug 2025 |
COMMON STOCK |
1,250 |
$23.69 |
Direct |
F2 |
| transaction |
LMND |
STOCK OPTION |
Options Exercise |
-$91,762 |
-3,750 |
-12.5% |
$24.47 |
26,250 |
05 Aug 2025 |
COMMON STOCK |
3,750 |
$24.47 |
Direct |
F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: